CSF tap test in idiopathic normal pressure hydrocephalus: still a necessary prognostic test?

OBJECTIVE: To assess whether gait, neuropsychological, and multimodal MRI parameters predict short-term symptom reversal after cerebrospinal fluid (CSF) tap test in idiopathic normal pressure hydrocephalus (iNPH). METHODS: Thirty patients (79.3 ± 5.9 years, 12 women) with a diagnosis of probable iNP...

Descripción completa

Detalles Bibliográficos
Autores principales: Griffa, Alessandra, Bommarito, Giulia, Assal, Frédéric, Preti, Maria Giulia, Goldstein, Rachel, Armand, Stéphane, Herrmann, François R., Van De Ville, Dimitri, Allali, Gilles
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9363476/
https://www.ncbi.nlm.nih.gov/pubmed/35598251
http://dx.doi.org/10.1007/s00415-022-11168-x
_version_ 1784764936906342400
author Griffa, Alessandra
Bommarito, Giulia
Assal, Frédéric
Preti, Maria Giulia
Goldstein, Rachel
Armand, Stéphane
Herrmann, François R.
Van De Ville, Dimitri
Allali, Gilles
author_facet Griffa, Alessandra
Bommarito, Giulia
Assal, Frédéric
Preti, Maria Giulia
Goldstein, Rachel
Armand, Stéphane
Herrmann, François R.
Van De Ville, Dimitri
Allali, Gilles
author_sort Griffa, Alessandra
collection PubMed
description OBJECTIVE: To assess whether gait, neuropsychological, and multimodal MRI parameters predict short-term symptom reversal after cerebrospinal fluid (CSF) tap test in idiopathic normal pressure hydrocephalus (iNPH). METHODS: Thirty patients (79.3 ± 5.9 years, 12 women) with a diagnosis of probable iNPH and 46 healthy controls (74.7 ± 5.4 years, 35 women) underwent comprehensive neuropsychological, quantitative gait, and multimodal MRI assessments of brain morphology, periventricular white-matter microstructure, cortical and subcortical blood perfusion, default mode network function, and white-matter lesion load. Responders were defined as an improvement of at least 10% in walking speed or timed up and go test 24 h after tap test. Univariate and multivariable tap test outcome prediction models were evaluated with logistic regression and linear support vector machine classification. RESULTS: Sixteen patients (53%) respondedpositively to tap test. None of the gait, neuropsychological, or neuroimaging parameters considered separately predicted outcome. A multivariable classifier achieved modest out-of-sample outcome prediction accuracy of 70% (p = .028); gait parameters, white-matter lesion load and periventricular microstructure were the main contributors. CONCLUSIONS: Our negative findings show that short-term symptom reversal after tap test cannot be predicted from single gait, neuropsychological, or MRI parameters, thus supporting the use of tap test as prognostic procedure. However, multivariable approaches integrating non-invasive multimodal data are informative of outcome and may be included in patient-screening procedures. Their value in predicting shunting outcome should be further explored, particularly in relation to gait and white-matter parameters. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00415-022-11168-x.
format Online
Article
Text
id pubmed-9363476
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-93634762022-08-11 CSF tap test in idiopathic normal pressure hydrocephalus: still a necessary prognostic test? Griffa, Alessandra Bommarito, Giulia Assal, Frédéric Preti, Maria Giulia Goldstein, Rachel Armand, Stéphane Herrmann, François R. Van De Ville, Dimitri Allali, Gilles J Neurol Original Communication OBJECTIVE: To assess whether gait, neuropsychological, and multimodal MRI parameters predict short-term symptom reversal after cerebrospinal fluid (CSF) tap test in idiopathic normal pressure hydrocephalus (iNPH). METHODS: Thirty patients (79.3 ± 5.9 years, 12 women) with a diagnosis of probable iNPH and 46 healthy controls (74.7 ± 5.4 years, 35 women) underwent comprehensive neuropsychological, quantitative gait, and multimodal MRI assessments of brain morphology, periventricular white-matter microstructure, cortical and subcortical blood perfusion, default mode network function, and white-matter lesion load. Responders were defined as an improvement of at least 10% in walking speed or timed up and go test 24 h after tap test. Univariate and multivariable tap test outcome prediction models were evaluated with logistic regression and linear support vector machine classification. RESULTS: Sixteen patients (53%) respondedpositively to tap test. None of the gait, neuropsychological, or neuroimaging parameters considered separately predicted outcome. A multivariable classifier achieved modest out-of-sample outcome prediction accuracy of 70% (p = .028); gait parameters, white-matter lesion load and periventricular microstructure were the main contributors. CONCLUSIONS: Our negative findings show that short-term symptom reversal after tap test cannot be predicted from single gait, neuropsychological, or MRI parameters, thus supporting the use of tap test as prognostic procedure. However, multivariable approaches integrating non-invasive multimodal data are informative of outcome and may be included in patient-screening procedures. Their value in predicting shunting outcome should be further explored, particularly in relation to gait and white-matter parameters. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00415-022-11168-x. Springer Berlin Heidelberg 2022-05-22 2022 /pmc/articles/PMC9363476/ /pubmed/35598251 http://dx.doi.org/10.1007/s00415-022-11168-x Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Communication
Griffa, Alessandra
Bommarito, Giulia
Assal, Frédéric
Preti, Maria Giulia
Goldstein, Rachel
Armand, Stéphane
Herrmann, François R.
Van De Ville, Dimitri
Allali, Gilles
CSF tap test in idiopathic normal pressure hydrocephalus: still a necessary prognostic test?
title CSF tap test in idiopathic normal pressure hydrocephalus: still a necessary prognostic test?
title_full CSF tap test in idiopathic normal pressure hydrocephalus: still a necessary prognostic test?
title_fullStr CSF tap test in idiopathic normal pressure hydrocephalus: still a necessary prognostic test?
title_full_unstemmed CSF tap test in idiopathic normal pressure hydrocephalus: still a necessary prognostic test?
title_short CSF tap test in idiopathic normal pressure hydrocephalus: still a necessary prognostic test?
title_sort csf tap test in idiopathic normal pressure hydrocephalus: still a necessary prognostic test?
topic Original Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9363476/
https://www.ncbi.nlm.nih.gov/pubmed/35598251
http://dx.doi.org/10.1007/s00415-022-11168-x
work_keys_str_mv AT griffaalessandra csftaptestinidiopathicnormalpressurehydrocephalusstillanecessaryprognostictest
AT bommaritogiulia csftaptestinidiopathicnormalpressurehydrocephalusstillanecessaryprognostictest
AT assalfrederic csftaptestinidiopathicnormalpressurehydrocephalusstillanecessaryprognostictest
AT pretimariagiulia csftaptestinidiopathicnormalpressurehydrocephalusstillanecessaryprognostictest
AT goldsteinrachel csftaptestinidiopathicnormalpressurehydrocephalusstillanecessaryprognostictest
AT armandstephane csftaptestinidiopathicnormalpressurehydrocephalusstillanecessaryprognostictest
AT herrmannfrancoisr csftaptestinidiopathicnormalpressurehydrocephalusstillanecessaryprognostictest
AT vandevilledimitri csftaptestinidiopathicnormalpressurehydrocephalusstillanecessaryprognostictest
AT allaligilles csftaptestinidiopathicnormalpressurehydrocephalusstillanecessaryprognostictest